2022
Association of the angiotensin I converting enzyme (ACE) gene polymorphisms with recurrent aphthous stomatitis in the Czech population: case-control study
BARTÁKOVÁ, Julie, Tereza DEISSOVÁ, Simona SLEZÁKOVÁ, Jirina BARTOVA, Jitka PETANOVA et. al.Základní údaje
Originální název
Association of the angiotensin I converting enzyme (ACE) gene polymorphisms with recurrent aphthous stomatitis in the Czech population: case-control study
Autoři
BARTÁKOVÁ, Julie (203 Česká republika, domácí), Tereza DEISSOVÁ (203 Česká republika, domácí), Simona SLEZÁKOVÁ (203 Česká republika, domácí), Jirina BARTOVA (203 Česká republika), Jitka PETANOVA (203 Česká republika), Pavel KUKLÍNEK (203 Česká republika, domácí), Antonín FASSMANN (203 Česká republika, domácí), Petra BOŘILOVÁ LINHARTOVÁ (203 Česká republika, domácí), Ladislav DUŠEK (203 Česká republika, domácí) a Lydie IZAKOVIČOVÁ HOLLÁ (203 Česká republika, garant, domácí)
Vydání
BMC Oral Health, London, BMC, 2022, 1472-6831
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30208 Dentistry, oral surgery and medicine
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.900
Kód RIV
RIV/00216224:14110/22:00125641
Organizační jednotka
Lékařská fakulta
UT WoS
000770760100002
Klíčová slova anglicky
Recurrent aphthous stomatitis; Angiotensin I converting enzyme; Polymorphism; Haplotype; Sex difference
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 3. 2023 13:45, Mgr. Tereza Miškechová
Anotace
V originále
Background Recurrent aphthous stomatitis (RAS) is multifactorial disease with unclear etiopathogenesis. The aim of this study was to determine distribution of the angiotensin I converting enzyme (ACE) gene polymorphisms and their influence on RAS susceptibility in Czech population. Methods The study included 230 subjects (143 healthy controls and 87 patients with RAS) with anamnestic, clinical and laboratory data. Five ACE gene polymorphisms (rs4291/rs4305/rs4311/rs4331/rs1799752 = ACE I/D) were determined by TaqMan technique. Results The allele and genotype distributions of the studied ACE I/D polymorphisms were not significantly different between subjects with/without RAS (P-corr > 0.05). However, carriers of II genotype were less frequent in the RAS group (OR = 0.48, 95% CI = 0.21-1.12, P = 0.059). Stratified analysis by sex demonstrated lower frequency of II genotype in women (OR = 0.33, 95% CI = 0.09-1.17, P < 0.035, P-corr > 0.05, respectively) than in men with RAS (P > 0.05). Moreover, the frequency of AGTGD haplotype was significantly increased in RAS patients (OR = 13.74, 95% CI = 1.70-110.79, P = 0.0012, P-corr < 0.05). In subanalysis, TGD haplotype was significantly more frequent in RAS patients (P < 0.00001) and CGI haplotype was less frequent in RAS patients (P < 0.01), especially in women (P = 0.016, P-corr > 0.05). Conclusions Our study indicates that while the AGTGD and TGD haplotypes are associated with increased risk of RAS development, CGI haplotype might be one of protective factors against RAS susceptibility in Czech population.
Návaznosti
MUNI/A/1445/2021, interní kód MU |
|